rs1558878

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001267727.2(ARSG):​c.820T>C​(p.Trp274Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.471 in 1,613,180 control chromosomes in the GnomAD database, including 182,582 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. W274Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.44 ( 14939 hom., cov: 34)
Exomes 𝑓: 0.47 ( 167643 hom. )

Consequence

ARSG
NM_001267727.2 missense

Scores

16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.255

Publications

30 publications found
Variant links:
Genes affected
ARSG (HGNC:24102): (arylsulfatase G) The protein encoded by this gene belongs to the sulfatase enzyme family. Sulfatases hydrolyze sulfate esters from sulfated steroids, carbohydrates, proteoglycans, and glycolipids. They are involved in hormone biosynthesis, modulation of cell signaling, and degradation of macromolecules. This protein displays arylsulfatase activity at acidic pH, as is typical of lysosomal sulfatases, and has been shown to localize in the lysosomes. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jun 2012]
ARSG Gene-Disease associations (from GenCC):
  • Usher syndrome, type 4
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Genomics England PanelApp, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Usher syndrome type 3
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.887314E-5).
BP6
Variant 17-68368663-T-C is Benign according to our data. Variant chr17-68368663-T-C is described in ClinVar as Benign. ClinVar VariationId is 1166454.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.494 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARSGNM_001267727.2 linkc.820T>C p.Trp274Arg missense_variant Exon 7 of 12 ENST00000621439.5 NP_001254656.1 Q96EG1A0A024R8K1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARSGENST00000621439.5 linkc.820T>C p.Trp274Arg missense_variant Exon 7 of 12 5 NM_001267727.2 ENSP00000480910.1 Q96EG1
ARSGENST00000448504.6 linkc.820T>C p.Trp274Arg missense_variant Exon 7 of 12 1 ENSP00000407193.2 Q96EG1
ARSGENST00000452479.6 linkc.328T>C p.Trp110Arg missense_variant Exon 6 of 11 5 ENSP00000413953.2 J9JIG6
ARSGENST00000582154.5 linkn.578T>C non_coding_transcript_exon_variant Exon 5 of 10 2

Frequencies

GnomAD3 genomes
AF:
0.436
AC:
66295
AN:
152126
Hom.:
14942
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.338
Gnomad AMI
AF:
0.589
Gnomad AMR
AF:
0.440
Gnomad ASJ
AF:
0.477
Gnomad EAS
AF:
0.244
Gnomad SAS
AF:
0.403
Gnomad FIN
AF:
0.492
Gnomad MID
AF:
0.487
Gnomad NFE
AF:
0.498
Gnomad OTH
AF:
0.432
GnomAD2 exomes
AF:
0.445
AC:
111488
AN:
250300
AF XY:
0.449
show subpopulations
Gnomad AFR exome
AF:
0.333
Gnomad AMR exome
AF:
0.448
Gnomad ASJ exome
AF:
0.470
Gnomad EAS exome
AF:
0.241
Gnomad FIN exome
AF:
0.495
Gnomad NFE exome
AF:
0.491
Gnomad OTH exome
AF:
0.465
GnomAD4 exome
AF:
0.475
AC:
693749
AN:
1460936
Hom.:
167643
Cov.:
53
AF XY:
0.474
AC XY:
344753
AN XY:
726758
show subpopulations
African (AFR)
AF:
0.330
AC:
11039
AN:
33432
American (AMR)
AF:
0.447
AC:
19894
AN:
44510
Ashkenazi Jewish (ASJ)
AF:
0.465
AC:
12145
AN:
26094
East Asian (EAS)
AF:
0.240
AC:
9513
AN:
39648
South Asian (SAS)
AF:
0.410
AC:
35346
AN:
86150
European-Finnish (FIN)
AF:
0.499
AC:
26655
AN:
53408
Middle Eastern (MID)
AF:
0.472
AC:
2719
AN:
5762
European-Non Finnish (NFE)
AF:
0.494
AC:
548820
AN:
1111566
Other (OTH)
AF:
0.458
AC:
27618
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.452
Heterozygous variant carriers
0
21362
42725
64087
85450
106812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15818
31636
47454
63272
79090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.436
AC:
66316
AN:
152244
Hom.:
14939
Cov.:
34
AF XY:
0.434
AC XY:
32343
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.338
AC:
14039
AN:
41522
American (AMR)
AF:
0.439
AC:
6720
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.477
AC:
1656
AN:
3470
East Asian (EAS)
AF:
0.243
AC:
1262
AN:
5184
South Asian (SAS)
AF:
0.403
AC:
1947
AN:
4826
European-Finnish (FIN)
AF:
0.492
AC:
5222
AN:
10616
Middle Eastern (MID)
AF:
0.493
AC:
145
AN:
294
European-Non Finnish (NFE)
AF:
0.498
AC:
33876
AN:
68006
Other (OTH)
AF:
0.432
AC:
913
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1979
3957
5936
7914
9893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
624
1248
1872
2496
3120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.473
Hom.:
85448
Bravo
AF:
0.429
TwinsUK
AF:
0.487
AC:
1804
ALSPAC
AF:
0.485
AC:
1870
ESP6500AA
AF:
0.346
AC:
1524
ESP6500EA
AF:
0.497
AC:
4276
ExAC
AF:
0.444
AC:
53872
Asia WGS
AF:
0.333
AC:
1160
AN:
3478
EpiCase
AF:
0.492
EpiControl
AF:
0.486

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Usher syndrome, type 4 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.049
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
8.4
DANN
Benign
0.46
DEOGEN2
Benign
0.28
T;T;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.0
FATHMM_MKL
Benign
0.017
N
LIST_S2
Benign
0.014
.;T;T
MetaRNN
Benign
0.000059
T;T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
-1.3
N;N;.
PhyloP100
0.26
PrimateAI
Benign
0.32
T
REVEL
Benign
0.073
Sift4G
Benign
1.0
T;T;T
Polyphen
0.0
B;B;.
Vest4
0.016
MutPred
0.22
Gain of disorder (P = 0.0088);Gain of disorder (P = 0.0088);.;
MPC
0.57
ClinPred
0.0053
T
GERP RS
4.3
Varity_R
0.093
gMVP
0.77
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1558878; hg19: chr17-66364804; COSMIC: COSV71593276; API